Concepedia

Dose Range Selection

Dose Range Selection is the methodological process of determining the span of drug doses to be evaluated in a study, distinguished by its role in enabling valid assessment of dose-proportionality in pharmacokinetic or pharmacodynamic responses.

96

Publications

5.8K

Citations

549

Authors

206

Institutions

Publications per year

2017–2026

19

Parents

Publications

96

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

Raymond Kwok, Kai Chow Choi, Grace Lai‐Hung Wong et al. · Gut · 2015 · 480 citations

, , +17

Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range?

Maciej Kabat, Ivan Bobkov, Suneel Kumar et al. · Stem Cells Translational Medicine · 2019 · 459 citations · Full text

, , +16

Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies

Shivaani Kummar, Robert J. Kinders, Martin Gutierrez et al. · Journal of Clinical Oncology · 2009 · 329 citations · Full text

, , +16

BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial

Ronald N. Marcus, Peter J. Goadsby, David W. Dodick et al. · Cephalalgia · 2013 · 292 citations

, , +16

Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer.

Paul B. Chapman, Tina Lester, E. S. Casper et al. · Journal of Clinical Oncology · 1987 · 220 citations

, , +11

1–5 of 96

Authors

549

  1. LR
    Larry Rubinstein

    National Cancer Institute, United States

    2 publications · 360 citations

    2

    h-index

  2. JH
    James H. Doroshow

    National Cancer Institute, United States

    2 publications · 360 citations

    2

    h-index

  3. MP
    Margaret Pittman

    National Institutes of Health, United States

    2 publications · 49 citations

    2

    h-index

  4. CJ
    Clifford J. Maloney

    National Institutes of Health, United States

    2 publications · 49 citations

    2

    h-index

  5. MC
    M. C. Hardegree

    Center for Biologics Evaluation and Research, United States

    2 publications · 49 citations

    2

    h-index

1–5 of 549

Institutions

206

  1. Eli Lilly (United States)

    Indianapolis, United States

    4 h-index

    8 publications

    658 citations

  2. Boehringer Ingelheim (United States)

    Ridgefield, United States

    4 h-index

    9 publications

    141 citations

  3. Boehringer Ingelheim (Germany)

    Ingelheim, Germany

    3 h-index

    6 publications

    304 citations

  4. Mayo Clinic in Arizona

    Scottsdale, United States

    3 h-index

    15 publications

    2K citations

  5. Pfizer (United States)

    New York, United States

    2 h-index

    5 publications

    281 citations

  6. Prince of Wales Hospital

    Shatin, China

    2 h-index

    2 publications

    573 citations

  7. Royal Children's Hospital

    Melbourne, Australia

    2 h-index

    5 publications

    114 citations

  8. The University of Texas at San Antonio Health Science Center

    San Antonio, United States

    2 h-index

    10 publications

    177 citations

1–8 of 206

Venues

  1. PubMed

    Repository · 12 publications · 538 citations

    11

    h-index

  2. Journal of Clinical Oncology

    4 publications · 590 citations

    4

    h-index

  3. International Journal of Toxicology

    IJT · 4 publications · 371 citations

    4

    h-index

  4. British Journal of Clinical Pharmacology

    BJCP · 2 publications · 29 citations

    2

    h-index

  5. Journal of Biopharmaceutical Statistics

    JBS · 2 publications · 203 citations

    2

    h-index

1–5